NYSE: ABBVAbbvie Inc Stock Ownership - Who owns Abbvie?
Insider buying vs selling
Have Abbvie Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| David Ryan Purdue | SVP Controller | 2026-03-04 | 5,230 | $233.56 | $1.22MSell |
| Perry C. Siatis | EVP GC AND SECRETARY | 2026-03-02 | 10,291 | $234.66 | $2.41MSell |
| Perry C. Siatis | EVP GC AND SECRETARY | 2026-03-02 | 2,600 | $235.26 | $611.68kSell |
| Perry C. Siatis | EVP GC AND SECRETARY | 2026-03-02 | 5,777 | $233.51 | $1.35MSell |
| David Ryan Purdue | SVP Controller | 2026-02-27 | 2,108 | $232.08 | $489.22kSell |
| Scott T. Reents | EVP CHIEF FINANCIAL OFFICER | 2026-02-27 | 21,638 | $232.08 | $5.02MSell |
| Roopal Thakkar | EVP RD and CSO | 2026-02-27 | 8,037 | $232.08 | $1.87MSell |
| Nicholas Donoghoe | EVP CHIEF BUSSTRAT OFFICER | 2026-02-27 | 12,874 | $232.08 | $2.99MSell |
| Robert A. Michael | CHAIRMAN OF THE BOARD AND CEO | 2026-02-27 | 36,523 | $232.08 | $8.48MSell |
| David Ryan Purdue | SVP Controller | 2026-02-27 | 2,692 | $232.08 | $624.76kSell |
ABBV insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ABBV insiders and whales buy or sell their stock.
ABBV Shareholders
What type of owners hold Abbvie Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 8.53% | 150,698,125 | $33.87B | Institution |
| Vanguard Capital Management LLC | 6.50% | 114,880,324 | $25.82B | Institution |
| State Street Corp | 4.60% | 81,217,516 | $18.26B | Institution |
| Jpmorgan Chase Co | 3.21% | 56,741,691 | $12.75B | Institution |
| Vanguard Portfolio Management LLC | 2.80% | 49,523,078 | $11.13B | Institution |
| Geode Capital Management LLC | 2.65% | 46,737,581 | $10.51B | Institution |
| Morgan Stanley | 2.15% | 38,016,774 | $8.55B | Institution |
| Capital Research Global Investors | 1.77% | 31,254,786 | $7.03B | Institution |
| Bank Of America Corp | 1.35% | 23,936,943 | $5.38B | Institution |
| Fmr LLC | 1.23% | 21,762,703 | $4.89B | Institution |
ABBV vs General Drug Manufacturer Stocks
Abbvie Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.